Raymond James & Associates Gain Therapeutics, Inc. Put Options Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GANX
# of Institutions
25Shares Held
2.74MCall Options Held
10KPut Options Held
0-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$1.09 Million0.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$1.05 Million0.04% of portfolio
-
Joel Greenblatt Gotham Asset Management, LLC | New York, Ny335KShares$618,9950.01% of portfolio
-
Hohimer Wealth Management, LLC330KShares$610,5000.1% of portfolio
-
Geode Capital Management, LLC Boston, MA272KShares$503,1480.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $22M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...